This study results revealed that expression of SH3PXD2A-AS1 was upregulated in DDP-resistant NSCLC cell line, whereas recent studies have also shown its upregulation in NSCLC and colorectal cancer [2, 10]. Here, SH3PXD2A is linked to colorectal cancer.